【ChiCTR-IOR-17013259】Breaking up Prolonged Sitting with Light-intensity Walking and Sitting Bouts Duration on Postprandial Metabolic Responses in Overweight/Obese Male Adults
ChiCTR-IOR-17013259
正在进行
/
/
/
2017-11-03
/
/
Overweight/Obesity
Breaking up Prolonged Sitting with Light-intensity Walking and Sitting Bouts Duration on Postprandial Metabolic Responses in Overweight/Obese Male Adults
Breaking up Prolonged Sitting with Light-intensity Walking and Sitting Bouts Duration on Postprandial Metabolic Responses in Overweight/Obese Male Adults
Breaking up Prolonged Sitting with Light-intensity Walking and Sitting Bouts Duration on Postprandial Metabolic Responses in Overweight/Obese Male Adults
随机交叉对照
其它
Randomized
Single-blind for Trial subjects
No
/
25
/
1990-01-01
1990-01-01
/
1. Chinese men aged between 18 and 34 years; 2. With overweight/obesity (Body Mass Index is higher than 22.9 km/m^2); 3. Physically inactive (moderate-intensity physical activity is less than 150 minutes per week for the past 3 months); 4. Total time spent sitting is more than 5 hours per day; 5. Fluent in English.；
请登录查看1. Allergic to milk or gluten; 2. With history of cardiovascular disease and/or diabetes; 3. Fasting blood glucose is over than 7 mmol/L, and/or 2-hour postprandial glucose in the 75-g Oral glucose tolerance test is over than 199 mg/dL, and/or HbA1C is over than 6.4%; 4. Smoker; 5. With conditions that alter limit capability to walk on a treadmill; 6. Taking any medications known to affect lipid or glucose metabolism; 7. Not fluent in English.；
请登录查看香港中文大學教育學院
/
香港中文大學教育學院的其他临床试验
Department of Sports Science and Physical Education, Faculty of Education, The Chinese University of Hong Kong的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 60
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04